Delaying the Onset of Disability in Patients With Multiple Sclerosis
Several factors contribute to the occurrence of disability in multiple sclerosis, but steps can be taken to prevent or delay its onset.
MS Insights
Detecting and Diagnosing Multiple Sclerosis in a Primary Care Setting
The nature of multiple sclerosis makes it unlikely to be accurately diagnosed upon first presentation.
The Promise of Metabolomics in Diagnosing and Precisely Treating MS
We explore the role of metabolomics in the diagnosis and treatment of multiple sclerosis and other diseases.
The Role of Telemedicine in the Treatment of Neuromuscular Disease
The acceleration of telemedicine during the pandemic has allowed us to gain vast insights into what works and what does not.
The Emerging Concept of a Prodrome in Multiple Sclerosis
Can an MS ”prodrome” be defined clinically? We discuss the work of researchers that attempts to answer this question.
The Growing Role of Antisense Oligonucleotides in MS Treatment
We explore the role of ASOs in MS treatment today, and why combination therapy may produce better clinical outcomes.
Assessing the Risk Factors for Relapse in Patients With NMOSD
In the management of any disease in which relapses are known to occur, it is important to identify the risk factors for their occurrence, as well as any other factors that might influence their severity. In this article, we will be assessing the risk factors for relapse in patients with neuromyelitis optica spectrum disorder (NMOSD)…
The Interaction Between Hypoxia and Inflammation in Multiple Sclerosis
We examine how hypoxia drives inflammation in multiple sclerosis—and how the opposite can happen as well.
The Blood-Brain Barrier and Development of Multiple Sclerosis Drugs
The blood-brain barrier is the guardian of the central nervous system, but its stubborn resistance to DMTs presents a unique problem to medical researchers.
The Potential of Cell-Based Therapies as a Treatment for Multiple Sclerosis
Cell-based therapies could potentially replace disease modifying therapies as the preferred choice of multiple sclerosis medication.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in MS Insights
Loading... 
Loading...